• Mon news: AZ obesity pill. 50% of drug shortages last at least 2 years. Pharmas and IRA lawsuit appeals. Novo-Ascendis biobucks deal. Wegovy reduces all-cause hospital admissions. See more on our front page

amgen

  1. NovaSeq platform helps Amgen's peer Illumina to raise forecast

    NovaSeq platform was debuted in January with a goal of lowering the cost of sequencing a human genome to $100. Illumina is expecting strong demand for this platform, which helped the firm to raise its outlook for the year. Check out the earnings highlights: https://alphastreet.com/bite/3af2cd8
    • Jim Rogers
    • Thread
    • amgen dna sequencing genomics illumina
    • Replies: 0
    • Forum: Amgen
Top Bottom
Back